Back
HFA Premium Access

Safety and efficacy of induced pluripotent stem cell-derived engineered human myocardium as biological ventricular assist tissue in term. heart failure (BioVAT-HF):trial design and experience at UKSH

Session: Heart failure with reduced ejection fraction (HFrEF) 3
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Speaker: Doctor C. Paitazoglou (Luebeck, DE)
Event: Heart Failure 2023

Congress Presentation

Add to my library

Like

About the speaker

Doctor Christina Paitazoglou

University Heart Center, Luebeck (Germany)
1 presentation
0 follower

6 more presentations in this session

Gender difference and clinical course of atrial fibrillation in patients with non-ischaemic cardiomyopathy

Speaker: Doctor I. Chung (Singapore, SG)

Access
Abstract
Slides
Like
Thumbnail

The relationship between the right ventricular function, cardiac catheterization and CPET parameters in patients with advanced heart failure

Speaker: Professor R. Acar (Istanbul, TR)

Access
Abstract
Slides
Like
Thumbnail

The first audit in real-world titration pattern of maximisation of four pillars of heart failure therapy to target doses in Irish nurse-led clinics.

Speaker: Ms C. Murphy (Wexford, IE)

Access
Abstract
Slides
Like
Thumbnail

Impact of heart failure evidence-based-therapy in hypotensive patients

Speaker: Doctor A. Fonseca (Porto, PT)

Access
Abstract
Slides
Like
Thumbnail

Identifying distinct clinical subgroups in heart failure with reduced ejection fraction

Speaker: Assistant Professor A. Uijl (Amsterdam, NL)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Heart failure with reduced ejection fraction (HFrEF) 3

Speakers: Doctor C. Paitazoglou, Doctor I. Chung, Professor R. Acar, Ms C. Murphy, Doctor A. Fonseca...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources